Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Potential biomarkers for early detection of acute graft-versus-host disease

G. Lochmanová, L. Jedličková, D. Potěšil, A. Tomancová, J. Verner, S. Pospíšilová, M. Doubek, J. Mayer, Z. Zdráhal,

. 2012 ; 6 (7-8) : 351-363.

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024336

Grantová podpora
NS9683 MZ0 CEP - Centrální evidence projektů

Acute graft-versus-host disease (aGVHD) is the main complication of allogeneic hematopoietic stem cell transplantation (HCT), resulting in considerable morbidity and mortality. Currently, the diagnosis of aGVHD is largely made based on clinical parameters and invasive biopsies. For the past 20 years, researchers have been trying to find reliable biomarkers to enable early and accurate diagnosis of aGVHD. Although a number of potential aGVHD biomarkers have been published, as yet, no validated diagnostic test is available. Proteomics encompasses a broad range of rapidly developing technologies, which have shown tremendous promise for early detection of aGVHD. In this article, we review the current state of aGVHD biomarker discovery, provide a summary of the key proteins of interest and the most common analytical procedures for the clinic, as well as outlining the significant challenges faced in their use.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13024336
003      
CZ-PrNML
005      
20141217095930.0
007      
ta
008      
130703s2012 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/prca.201100104 $2 doi
035    __
$a (PubMed)22927351
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Lochmanová, Gabriela $u Core Facility-Proteomics, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
245    10
$a Potential biomarkers for early detection of acute graft-versus-host disease / $c G. Lochmanová, L. Jedličková, D. Potěšil, A. Tomancová, J. Verner, S. Pospíšilová, M. Doubek, J. Mayer, Z. Zdráhal,
520    9_
$a Acute graft-versus-host disease (aGVHD) is the main complication of allogeneic hematopoietic stem cell transplantation (HCT), resulting in considerable morbidity and mortality. Currently, the diagnosis of aGVHD is largely made based on clinical parameters and invasive biopsies. For the past 20 years, researchers have been trying to find reliable biomarkers to enable early and accurate diagnosis of aGVHD. Although a number of potential aGVHD biomarkers have been published, as yet, no validated diagnostic test is available. Proteomics encompasses a broad range of rapidly developing technologies, which have shown tremendous promise for early detection of aGVHD. In this article, we review the current state of aGVHD biomarker discovery, provide a summary of the key proteins of interest and the most common analytical procedures for the clinic, as well as outlining the significant challenges faced in their use.
650    _2
$a akutní nemoc $7 D000208
650    _2
$a biologické markery $x analýza $7 D015415
650    _2
$a časná diagnóza $7 D042241
650    _2
$a nemoc štěpu proti hostiteli $x diagnóza $x metabolismus $7 D006086
650    _2
$a lidé $7 D006801
650    _2
$a proteomika $7 D040901
650    _2
$a odběr biologického vzorku $7 D013048
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Jedličková, Lenka $u -
700    1_
$a Potěšil, David $u -
700    1_
$a Tomancová, Alexandra $u -
700    1_
$a Verner, Jan $u -
700    1_
$a Pospíšilová, Sárka $u -
700    1_
$a Doubek, Michael $u -
700    1_
$a Mayer, Jiří $u -
700    1_
$a Zdráhal, Zbyněk $u -
773    0_
$w MED00157628 $t Proteomics. Clinical applications $x 1862-8354 $g Roč. 6, č. 7-8 (2012), s. 351-363
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22927351 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20141217100039 $b ABA008
999    __
$a ok $b bmc $g 988016 $s 822716
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 6 $c 7-8 $d 351-363 $i 1862-8354 $m Proteomics. Clinical applications $n Proteomics Clin Appl $x MED00157628
GRA    __
$a NS9683 $p MZ0
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Možnosti archivace